Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20036440HPVENSG00000078070.14protein_codingMCCC1NoNo56922A0A0S2Z693
Q96RQ3
TVIS20057084HPVENSG00000078070.14protein_codingMCCC1NoNo56922A0A0S2Z693
Q96RQ3
TVIS20031632HPVENSG00000078070.14protein_codingMCCC1NoNo56922A0A0S2Z693
Q96RQ3
TVIS20025033HPVENSG00000078070.14protein_codingMCCC1NoNo56922A0A0S2Z693
Q96RQ3
TVIS44025026HTLV-1ENSG00000078070.14protein_codingMCCC1NoNo56922A0A0S2Z693
Q96RQ3
TVIS44038278HTLV-1ENSG00000078070.14protein_codingMCCC1NoNo56922A0A0S2Z693
Q96RQ3
TCGA Plot Options
Drug Information
GeneMCCC1
DrugBank IDDB00121
Drug NameBiotin
Target IDBE0000445
UniProt IDQ96RQ3
Regulation Typecofactor
PubMed IDs16773504; 16772434
CitationsFriebel D, von der Hagen M, Baumgartner ER, Fowler B, Hahn G, Feyh P, Heubner G, Baumgartner MR, Hoffmann GF: The first case of 3-methylcrotonyl-CoA carboxylase (MCC) deficiency responsive to biotin. Neuropediatrics. 2006 Apr;37(2):72-8.@@Hassan YI, Zempleni J: Epigenetic regulation of chromatin structure and gene function by biotin. J Nutr. 2006 Jul;136(7):1763-5.
GroupsApproved; Investigational; Nutraceutical
Direct ClassificationBiotin and derivatives
SMILES[H][C@]12CS[C@@H](CCCCC(O)=O)[C@@]1([H])NC(=O)N2
PathwaysMitochondrial Complex II Deficiency; 3-Methylglutaconic Aciduria Type III; 2-Ketoglutarate Dehydrogenase Complex Deficiency; 4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency; Isovaleric Aciduria; Pyruvate Carboxylase Deficiency; Warburg Effect; Isobutyryl-CoA Dehydrogenase Deficiency; Biotin Metabolism; Fructose-1,6-diphosphatase Deficiency; Methylmalonic Aciduria Due to Cobalamin-Related Disorders; Propionic Acidemia; Transfer of Acetyl Groups into Mitochondria; Malonic Aciduria; 2-Hydroxyglutric Aciduria (D and L Form); 3-Methylcrotonyl-CoA Carboxylase Deficiency Type I; Congenital Lactic Acidosis; 3-Hydroxy-3-methylglutaryl-CoA Lyase Deficiency; Fumarase Deficiency; Succinic Semialdehyde Dehydrogenase Deficiency; Alanine Metabolism; Methylmalonic Aciduria; 3-Methylglutaconic Aciduria Type IV; Lactic Acidemia; Glycogen Storage Disease Type 1A (GSD1A) or Von Gierke Disease; Primary Hyperoxaluria Type I; Triosephosphate Isomerase; The Oncogenic Action of 2-Hydroxyglutarate; Valine, Leucine, and Isoleucine Degradation; Maple Syrup Urine Disease
PharmGKBPA448625
ChEMBLCHEMBL857